$57.60
0.200.35%
Last update: Oct 29, 9:27 AM
TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History
TGTXNASDAQ
B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for the sector during the Q3 2026 earnings season.
You can purchase shares of TG Therapeutics (NASDAQ:TGTX) through any online brokerage.
Other companies in TG Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
TG Therapeutics has a consensus price target of $51.45.
The stock price for TG Therapeutics (NASDAQ: TGTX) is $57.6 last updated October 29, 2026 at 9:27 AM EDT.
There are no upcoming dividends for TG Therapeutics.
TG Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for TG Therapeutics.
TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval...
